Thermo Fisher Scientific SERPINA3 Monoclonal Antibody (1AC10-128.1)

Applications

Tested Dilution

Publications

ELISA (ELISA)

1-10 µg/mL

-

Product Specifications

Species Reactivity

Human

Host/Isotype

Mouse / IgG1

Class

Monoclonal

Type

Antibody

Clone

1AC10-128.1

Immunogen

Purified human serum alpha-1 Antichymotrypsin. if (typeof window.$mangular === undefined || !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{targetFamily:SERPINA3,uniProtId:P01011-1,ncbiNodeId:9606,antigenRange:1-423,antigenLength:423,antigenImageFileName:MA1-10631_SERPINA3_P01011-1_House_mouse.svg,antigenImageFileNamePDP:MA1-10631_SERPINA3_P01011-1_House_mouse_PDP.jpeg,sortOrder:1}\]; $mangular.isB2BCMGT = false; $mangular.isEpitopesModalImageMultiSizeEnabled = true;

View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1 mg/mL

Purification

Protein G

Storage buffer

PBS, pH 7.4

Contains

no preservative

Storage conditions

-20° C, Avoid Freeze/Thaw Cycles

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_1070294

Product Specific Information

MA1-10631 detects alpha-1 Antichymotrypsin from human samples.

MA1-10631 has been successfully used in ELISA applications.

The MA1-10631 immunogen is purified human serum alpha-1 Antichymotrypsin.

Target Information

SERPINA encodes Alpha 1-ACT. It is an early-stage acute-phase plasma protein and a serpin that preferentially inactivates chymotrypsin, cathepsin G, and chymase. Alpha-1-ACT, a serine protease inhibitor, is tightly associated with amyloid plaques in Alzheimer`s disease (AD) and in normal aged human and monkey brain. Regulation of the serine proteases and serine protease inhibitors plays an important role in neuromuscular differentiation. Prostate specific antigen (PSA), a chymotrypsin-like serine protease, is predominantly complexed to Alpha-1-ACT.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.